US President Barack Obama has sought $215 million for an effort that will match patients' genetic and physiological data to treat their health conditions more precisely.
Obama proposed the plan, known as the "Precision Medicine Initiativea, in his annual State of the Union address last week.
Details of the plan come as Obama prepares to release his fiscal year 2016 budget request to Congress Feb 2, the scientific journal Nature reported.
The White House is seeking $130 million for the US National Institutes of Health (NIH) to develop a national cohort of at least one million volunteers for a longitudinal study.
Their medical, physiological and genomic data would be integrated in a massive database that would be made available to researchers.
The US Food and Drug Administration would receive $10 million to build databases to support precision-medicine research and regulation as part of the initiative.
According to Keith Yamamoto, biologist at the University of California, San Francisco, the budget outlined by Obama will not be sufficient to achieve the programme's goals.
"It is not even close," Yamamoto added.
But he is optimistic that researchers working for the programme would still discover genetic correlations and risk factors for disease that could improve treatments.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
